BioCentury | Sep 22, 2014
Financial News

Synereca completes venture financing

Synereca Pharmaceuticals Inc. , Oklahoma City, Okla. Business: Infectious Date completed: 2014-09-16 Type: Venture financing Raised: $1.4 million Investors: Accele Venture Partners I L.P.; i2E Inc. Note: The financing is convertible debt. WIR Staff...
BioCentury | Mar 3, 2014
Company News

Synereca management update

Synereca Pharmaceuticals Inc. , Oklahoma City, Okla. Business: Infectious Hired: Clayton Duncan, CEO and chairman of Accele Biopharma Inc., as CEO and chairman; Richard Gammans as president and COO; Kelle Jones as CFO; and Scott Singleton...
BioCentury | Mar 3, 2014
Financial News

Synereca completes venture financing

Synereca Pharmaceuticals Inc. , Oklahoma City, Okla. Business: Infectious Date completed: 2/26/14 Type: Venture financing Raised: $500,000 Investor: Accele Venture Partners I WIR Staff Infectious...
Items per page:
1 - 3 of 3
BioCentury | Sep 22, 2014
Financial News

Synereca completes venture financing

Synereca Pharmaceuticals Inc. , Oklahoma City, Okla. Business: Infectious Date completed: 2014-09-16 Type: Venture financing Raised: $1.4 million Investors: Accele Venture Partners I L.P.; i2E Inc. Note: The financing is convertible debt. WIR Staff...
BioCentury | Mar 3, 2014
Company News

Synereca management update

Synereca Pharmaceuticals Inc. , Oklahoma City, Okla. Business: Infectious Hired: Clayton Duncan, CEO and chairman of Accele Biopharma Inc., as CEO and chairman; Richard Gammans as president and COO; Kelle Jones as CFO; and Scott Singleton...
BioCentury | Mar 3, 2014
Financial News

Synereca completes venture financing

Synereca Pharmaceuticals Inc. , Oklahoma City, Okla. Business: Infectious Date completed: 2/26/14 Type: Venture financing Raised: $500,000 Investor: Accele Venture Partners I WIR Staff Infectious...
Items per page:
1 - 3 of 3